Brainsway Ltd. announced the appointment of Yaacov Michlin as CEO. Mr. Michlin brings two decades of experience in growing biomedical organizations. His proficiency in corporate finance, capital markets and business management and development has played a crucial role in the success of leading organizations throughout the biotech industry. He joined Brainsway in 2015 serving as a director on its board providing exceptional guidance. For the past seven years, Mr. Michlin has served as president and CEO of Yissum.